SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹3.32 Cr | ₹-40 Cr | ₹-242 Cr | ₹-156 Cr | ₹-76 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹3.32 Cr |
| Mar2024 | ₹-40 Cr |
| Mar2023 | ₹-242 Cr |
| Mar2022 | ₹-156 Cr |
| Mar2021 | ₹-76 Cr |
How is Cash Flow from Financing Activities of SUVEN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.32 Cr | Positive | |
| Mar2024 | ₹-40 Cr | Negative | |
| Mar2023 | ₹-242 Cr | Negative | |
| Mar2022 | ₹-156 Cr | Negative | |
| Mar2021 | ₹-76 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹15,952.5 Cr | -10.4% | -20.9% | -58% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -10.4% |
-20.9% |
-58% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses